Loss-of-function mutations in SMARCB1 have been identified as a cause of various histologic tumors [1], including epithelioid sarcomas, schwannomatosis, synovial sarcomas, and myoepithelial carcinomas. The gene discussed is SMARCB1; the disease is epithelioid sarcoma.